FDA panel votes to place popular peptide BPC-157 on compounding list
HIMS•FDA advisory panel backs broader compounding for BPC-157
July 23 (Reuters) - A panel of advisers to the U.S. Food and Drug Administration on Thursday voted to place a widely used peptide called BPC-157 on a list that would allow broader pharmacy compounding.
Eight panel members voted in favor, while six members voted against it. One member abstained.
